Enanta Pharmaceuticals Inc. sell JPMorgan Chase & Co.
Start price
06.08.24
/
50%
€11.50
Target price
06.08.25
€9.15
Performance (%)
-4.35%
Price
07.08.24
€11.00
Summary
This prediction is currently active. With a performance of -4.35%, the SELL prediction by JPMorgan_Chase___Co_ is trending in the right direction. This prediction currently runs until 06.08.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Enanta Pharmaceuticals Inc. | -4.35% |
iShares Core DAX® | -5.630% |
iShares Nasdaq 100 | -8.559% |
iShares Nikkei 225® | -9.576% |
iShares S&P 500 | -6.631% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) had its price target lowered by analysts at JPMorgan Chase & Co. from $11.00 to $10.00. They now have an "underweight" rating on the stock.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.70
09.08.23
09.08.23
€12.75
09.08.24
09.08.24
-25.17%
07.08.24
07.08.24